[1]
“Compaction and Tableting Behavior of a Novel Co-Processed Excipient in the Formulation of Metoprolol Succinate Tablets”, NJPR, c. 16, sy 2, ss. 127–142, Ara. 2020, doi: 10.4314/njpr.v16i2.4.